Augmedix, Inc. (AUGX)

Augmedix Income Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	48.7	44.86	30.93	22.17	16.48	14.11
Revenue Growth (YoY)	45.04%	45.01%	39.56%	34.47%	16.84%	30.44%
Cost of Revenue	25.22	23.33	16.98	12.16	9.69	9.43
Gross Profit	23.48	21.53	13.95	10.01	6.79	4.68
Selling, General & Admin	31.27	29.13	26.18	20.88	15.97	14.44
Research & Development	12.3	11.18	10.15	6.68	4.52	6.98
Operating Expenses	43.57	40.31	36.33	27.56	20.49	21.42
Operating Income	-20.09	-18.78	-22.37	-17.55	-13.69	-16.74
Interest Expense / Income	2.46	2.25	1.68	2.25	1.45	2.81
Other Expense / Income	-2.15	-2.01	0.29	-2.39	0.46	-1.06
Pretax Income	-20.4	-19.03	-24.34	-17.42	-15.6	-18.5
Income Tax	0.03	0.15	0.11	0.05	0	0
Net Income	-20.43	-19.17	-24.45	-17.46	-15.6	-18.5
Shares Outstanding (Basic)	53	44	37	29	7	1
Shares Outstanding (Diluted)	53	44	37	29	7	1
Shares Change	41.52%	17.45%	29.41%	311.09%	745.81%	-30.08%
EPS (Basic)	-0.43	-0.44	-0.65	-0.60	-2.22	-22.24
EPS (Diluted)	-0.43	-0.44	-0.65	-0.60	-2.22	-22.24
Free Cash Flow	-20.93	-18.55	-18.18	-19.2	-15.05	-15.47
Free Cash Flow Per Share	-0.39	-0.42	-0.49	-0.66	-2.14	-18.60
Gross Margin	48.22%	47.99%	45.11%	45.15%	41.22%	33.17%
Operating Margin	-41.25%	-41.87%	-72.32%	-79.18%	-83.07%	-118.68%
Profit Margin	-41.95%	-42.74%	-79.04%	-78.79%	-94.67%	-131.12%
Free Cash Flow Margin	-42.98%	-41.35%	-58.78%	-86.64%	-91.28%	-109.65%
EBITDA	-15.53	-14.63	-21.14	-14.47	-13.28	-14.74
EBITDA Margin	-31.89%	-32.62%	-68.33%	-65.30%	-80.59%	-104.46%
Depreciation & Amortization	2.41	2.14	1.53	0.69	0.87	0.95
EBIT	-17.94	-16.77	-22.66	-15.17	-14.15	-15.69
EBIT Margin	-36.84%	-37.39%	-73.26%	-68.42%	-85.85%	-111.19%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).